Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference27 articles.
1. Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey (2018) Available from: https://clincalc.com/DrugStats/Drugs/Fluorouracil
2. Van Halteren HK, Roumen RM, Coebergh JW, Croiset van Uchelen FA, Keuning JJ, Vreugdenhil G (1999) The impact of 5-FU-based bolus chemotherapy on survival in patients with advanced colorectal cancer. Anticancer Res 19(4C):3447–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10629633
3. Delea TE et al (2002) The incidence and cost of hospitalization for 5-FU toxicity among medicare beneficiaries with metastatic colorectal cancer. Value in Health 5(1):35–43. https://doi.org/10.1046/j.1524-4733.2002.51083.x
4. Rosmarin D et al (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol 32(10):1031–1039. https://doi.org/10.1200/JCO.2013.51.1857
5. Knikman JE, Gelderblom H, Beijnen JH, Cats A, Guchelaar H, Henricks LM (2020) Individualized dosing of fluoropyrimidine‐based chemotherapy to prevent severe fluoropyrimidine‐related toxicity: what are the options? Clin Pharmacol Ther cpt.2069. https://doi.org/10.1002/cpt.2069
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献